Clinical trial
Telmisartan and Losartan in Hypertensive IGT
NCT00407862 · Medical University of Graz, Other · Completed
Key facts
| NCT number | NCT00407862 |
|---|---|
| Title | Telmisartan and Losartan in Hypertensive IGT |
| Official title | Telmisartan vs. Losartan in Hypertensive Patients With Impaired Glucose Tolerance: A Comparison of Their Antihypertensive, Metabolic, and Vascular Effects |
| Lead sponsor | Medical University of Graz, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension, Impaired Glucose Tolerance |
| Intervention type | Drug |
| Interventions | Telmisartan 80 mg, Losartan 50 mg |
| Enrollment | 24 |
| Start date | Jan 1, 2005 |
| Completion | Jun 1, 2006 |
| First posted | Dec 5, 2006 |
| Last update posted | Dec 5, 2006 |
| Countries | Austria |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: